We published a review article titled “Redox changes in obesity, metabolic syndrome, and diabetes” in the Redox Biology journal about the diversity and clinical utility of redox biomarkers in redox-metabolic diseases like obesity, metabolic syndrome, and diabetes. We took a unique approach discussing redox biomarkers in metabolic diseases in the context of circadian rhythms and obesity-associated malignancies. You can access the full article below, or at the following links:
https://www.sciencedirect.com/science/article/pii/S2213231721000355?via%3Dihub